Boulder Hill Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,000
Closed -$767K 125
2022
Q1
$767K Buy
+6,000
New +$656K 0.41% 71

Other funds holding DXCM

Boulder Hill Capital Management's DXCM Position: Q2 2022 in Review

Boulder Hill Capital Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 6,000 shares — an estimated $767K sold.

Boulder Hill Capital Management first reported a position in DXCM in Q1 2022 and held it in 1 quarter. The position peaked at $767K in Q1 2022. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Boulder Hill Capital Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 6,000 DexCom shares in Q2 2022, an estimated $767K.
  • Boulder Hill Capital Management first reported a position in DexCom in Q1 2022 and held it in 1 quarter.
  • Boulder Hill Capital Management's DexCom position peaked at $767K in Q1 2022.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Boulder Hill Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.